Description
Now completely updated! The essential guide for people with melanoma.
In Beating Melanoma, world-renowned skin cancer expert Dr. Steven Q. Wang provides an indispensable guide for those diagnosed with melanoma. Now in its second edition and completely revised, this practical guide offers up-to-date research on the diagnosis, treatment, and prevention of melanoma, and a readable narrative that demystifies everything from the pathology report to the stages of cancer. This new edition features updated information on new immunotherapies and targeted therapies, as well as access to online interviews with more than 25 leading melanoma experts from fields including dermatology, medical oncology, surgical oncology, radiation oncology, dermatopathology, and genetics.
Beating Melanoma approaches the disease in two phases. First, Dr. Wang lays out a step-by-step guide for approaching the "mad rush" phase--an intense and stressful period from diagnosis to completing initial treatment. Dr. Wang's calm guidance helps readers through this critical time with an easy-to-understand plan for ensuring optimal treatment and survival outcomes. Once the mad rush phase is over, the "marathon phase" begins--life resumes its normal shape but with lingering concerns about new melanoma and metastases. Here Dr. Wang addresses common questions about prevention and prognosis. This guide is a thorough, comforting, and informative book for melanoma patients and their families.
Author: Steven Q. Wang
Publisher: Johns Hopkins University Press
Published: 05/21/2024
Pages: 184
Binding Type: Paperback
Weight: 0.52lbs
Size: 8.49h x 5.55w x 0.48d
ISBN13: 9781421449487
ISBN10: 142144948X
BISAC Categories:
- Health & Fitness | General
- Medical | Public Health
- Medical | Hematology
About the Author
Steven Q. Wang, MD, is the director of dermatologic oncology at Hoag Memorial Hospital Presbyterian, where he specializes in the prevention, diagnosis, and treatment of skin cancer. He has been featured as a skin cancer expert in the New York Times, the Washington Post, and the Wall Street Journal.